mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.21 |
0.002 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |